Nicotinell (Nicotine)

The nicotine in Nicotinell penetrates the skin and binds to nicotinic acetylcholine receptors in the brain, mimicking the pharmacologic effect of cigarette smoke. This receptor stimulation lessens the intensity of withdrawal and cravings, while the gradual decline in plasma nicotine levels supports a stepwise reduction of dependence. The steady delivery also moderates catecholamine surges that can affect cardiovascular responses.

The appropriate dose of Nicotinell is determined by the prescribing healthcare professional based on the individual’s smoking history, level of nicotine dependence, and previous cessation attempts. The prescriber selects the patch strength and duration that best matches the patient’s needs, and may adjust the regimen over time. Patients should follow the specific instructions provided by their clinician and the product label.

Safety data for nicotine patches in pregnancy and lactation are limited, and the potential risks to the fetus or infant are not fully established. Health professionals generally advise that Nicotinell should be avoided unless the expected benefit of quitting smoking outweighs possible harm. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative cessation strategies with their physician.

To place an order, submit an enquiry on the Nicotinell product page at gnhindia.com, specifying the required quantity and intended use. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any special handling requirements—and assists with the necessary import documentation.

Compared with nicotine gum or lozenges, the Nicotinell patch offers continuous, steady‑state nicotine delivery, eliminating the need for frequent dosing and reducing oral irritation. Unlike inhalers, it does not simulate the hand‑to‑mouth action of smoking, which may be less satisfying for some users. The patch’s once‑daily application can improve adherence, but individuals who prefer rapid dose adjustments may find short‑acting forms more flexible.

Nicotinell patches should be stored at room temperature, below 25 °C, in their original sealed packaging. Keep them away from direct sunlight, moisture, and heat sources such as radiators. Do not expose the patches to temperatures above the recommended range, as this may affect nicotine stability and adhesive performance. Ensure the packaging remains intact until the patch is applied.

The patch is applied to clean, dry, hair‑free skin on the upper arm, chest, or back, avoiding areas with cuts, irritation, or excessive hair. Press the patch firmly for about 10 seconds to ensure good contact. A new patch is typically applied once every 24 hours, and the previous patch should be removed and disposed of safely. Users should rotate application sites to minimize skin irritation.

The most serious risks include severe allergic reactions such as anaphylaxis, extensive skin necrosis at the application site, and cardiovascular events like chest pain, hypertension, or arrhythmias. Rarely, nicotine toxicity can lead to seizures or profound hypotension. Patients experiencing any of these symptoms should discontinue use immediately and seek emergency medical attention.

Nicotinell is not recommended for individuals under 18 years of age, non‑smokers, or those who are pregnant or breastfeeding unless a physician determines that the benefits outweigh the risks. It should also be avoided by patients with recent myocardial infarction, uncontrolled hypertension, or severe skin disorders at the intended application sites. Consultation with a healthcare provider is essential before initiating therapy.